HOME >> MEDICINE >> NEWS
Millions wasted on blood pressure tablets

Millions of dollars are being spent unnecessarily each year on treatments for high blood pressure says research published this week in BMC Health Services Research. Vast amounts could be saved if doctors prescribed thiazides, the recommended and cheapest drugs, rather than expensive alternatives.

Atle Fretheim and his colleagues from the Norwegian Directorate for Health and Social Affairs estimated the potential annual savings for six countries if thiazides were prescribed whenever there was no reason to use an alternative. The savings could be huge: Canada - US$13.8m, France - US$37.4m, Germany - US$72.2m, Norway - US$10.7m, UK - US$119.7m and US - US$433.6m.

"Our calculations are based on conservative estimates. The potential for saving is likely to be considerably higher, and may be over US$1billion per year in the US," write the researchers.

To produce these estimates, the researchers used sales, prescription and survey data to estimate the number of people in each country that were being treated for high blood pressure, and the proportion of those that were taking thiazides. The proportion varied between countries from 12% to 40%. Previously published research suggests that thiazides could be used effectively in at least 45% of all cases. Armed with this information, the researchers worked out the potential annual cost savings to health services. They calculated the costs of increasing thiazide usage to its limit, and the resulting cost reductions of other treatments, assuming these reductions would be distributed evenly across those treatments.

All clinical guidelines recommend thiazides as a first choice drug for treating uncomplicated high blood pressure. This is because no drug to treat high blood pressure has been identified as being clearly superior to the others, and the evidence that thiazides reduce the risk of stroke and heart disease is strong. Thiazides are also amongst the best tolerated drugs, and are by far
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-207-323-0323
BioMed Central
7-Sep-2003


Page: 1 2

Related medicine news :

1. Millions who suffer from nut and milk allergies could benefit from Stanford researchers test
2. Millions of Asian Americans and Pacific Islanders at increased risk for type 2 diabetes
3. Millions turn a blind eye to dangerous driving
4. Millions of Americans are failing to get recommended health care
5. Millions of migraine sufferers could benefit from better use of medical care
6. Millions Of Americans With Glaucoma Could Save Sight With Early Detection, Treatment
7. Engineering Study For The CDC Shows How To Fight Low Childhood Immunization,Save Millions In Health Costs
8. A marker for new blood vessel formation in tumors
9. Acupuncture found to lower elevations in blood pressure
10. Diagnostic test for range of blood disorders on the horizon
11. Research suggests possible blood test for multiple sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... in many scientific laboratories. The assembly protocols involve many repetitive steps and often ... for automation, which enables the high-throughput needed, and results in a lower error ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... Hills of Pittsburgh now have easier access to the robotic-assisted total-hip and ... Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson Hospital recently ...
(Date:3/29/2017)... ... March 29, 2017 , ... AvePoint , the ... American office location in Richmond, Virginia, located at the Riverfront Plaza, 901 East Byrd ... Lieutenant Governor of Virginia Ralph S. Northam and Mayor of Richmond Levar M. Stoney. ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... Tuesday, ... asking the American public to take the Diabetes Risk Test to find out if ... the Los Angeles World Airports will light up the evening sky by programming the ...
(Date:3/28/2017)... CARTERSVILLE, Georgia (PRWEB) , ... March 28, 2017 ... ... analyst to its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, ... been a leader in the real estate valuation industry for more than 40 ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Varian Medical Systems (NYSE: VAR ... second quarter of fiscal year 2017 following the close of ... will be followed by a teleconference available to all interested ... link to the conference call webcast will be available on ... teleconference call and replay: ...
(Date:3/29/2017)... , March 29, 2017   Royal Philips ... in health technology, and PathAI, a company that ... with the aim to develop solutions that improve ... cancer and other diseases. The partnership aims to ... this form of artificial intelligence to be applied ...
(Date:3/29/2017)... , March 29, 2017 Neurim Pharmaceuticals ... Exeltis will obtain exclusive marketing rights for Neurim,s new Rx PedPRM ... ... targeted to treat sleep disorders in children with Autism Spectrum Disorders ... sleep medication approved for children. The collaboration with Exeltis ...
Breaking Medicine Technology:
Cached News: